Mediphage Bioceuticals, Inc.
Toronto, Canada
|
Description:
Mediphage Bioceuticals, Inc. is a preclinical-stage biotechnology company, which is developing a next-generation non-viral gene delivery platform based on its proprietary ministring DNA (msDNA) technology. The company uses a proprietary manufacturing platform to develop safe, durable, and redosable gene delivery vectors. msDNA, a versatile platform, is designed to overcome critical challenges facing viral gene therapies and leverage advancements in non-viral gene delivery.
Mediphage Bioceuticals, Inc. is a preclinical-stage biotechnology company, which is developing a next-generation non-viral gene delivery platform based on its proprietary ministring DNA (msDNA) technology. The company uses a proprietary manufacturing platform to develop safe, durable, and redosable gene delivery vectors. msDNA, a versatile platform, is designed to overcome critical challenges facing viral gene therapies and leverage advancements in non-viral gene delivery.